Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,39
KB0,43
PKN121121,70,75
Msft1,16
IBM0,73
DCX68,3368,36-0,84
PFE0,50
21.10.2017 1:03:50
Indexy online
AD Index online
select
AD Index online
 

  • 20.10.2017 22:00:00
Inogen (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
96,65 2,11 2,00 107 657
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiInogen Inc
TickerINGN
Kmenové akcie:Ordinary Shares
RICINGN.O
ISINUS45780L1044
Poslední známé roční výsledky31.12.2016
Poslední známé čtvrtletní výsledky30.6.2017
Počet zaměstnanců k 31.12.2016 602
Akcie v oběhu k 28.7.2017 20 726 405
Počet akcionářů k 31.12.2016 18
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice326 Bollay Dr
MěstoGOLETA
PSČ93117-5550
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 055 620 500
Fax13026365454

Business Summary: Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.
Financial Summary: BRIEF: For the six months ended 30 June 2017, Inogen Inc revenues increased 20% to $116.6M. Net income increased 43% to $14.3M. Revenues reflect Sales revenue increase of 33% to $104M. Net income benefited from Other income (expense) increase from $86K to $730K (income), Interest Income increase from $65K to $247K (income), Interest Expense decrease from $5K (expense) to $0K.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
SICElectromedical Equipment
SICSurgical And Medical Instruments



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardHeath Lukatch491.1.2008
President, Chief Executive Officer, DirectorScott Wilkinson521.3.20171.1.2008
Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate TreasurerAlison Bauerlein35
Executive Vice President of Sales and MarketingByron Myers371.1.20171.1.2011
Executive Vice President - OperationsMatthew Scribner49
Executive Vice President - EngineeringBrenton Taylor35